The JSE tracked firmer global markets on Monday after another Covid-19 vaccine developer reported encouraging results from its trials, while Shoprite lost the most on the day.

American biotechnology group Moderna said on Monday that its preliminary phase 3 trial data showed its  Covid-19 vaccine was more than 94% effective — a result CEO Stephane Bancel called a “game changer”...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now